🇺🇸 FDA
Pipeline program

EDP-721

EDP 721-001

Phase 1 small_molecule terminated

Quick answer

EDP-721 for Chronic Hepatitis B Virus Infection is a Phase 1 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ENANTA PHARMACEUTICALS INC
Indication
Chronic Hepatitis B Virus Infection
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials